相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib
Jenny J. Kim et al.
CANCER (2012)
Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels
Stephanie Debette et al.
CIRCULATION RESEARCH (2011)
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
Jesus Garcia-Donas et al.
LANCET ONCOLOGY (2011)
The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer
T. F. Hansen et al.
PHARMACOGENOMICS JOURNAL (2011)
VEGF-460T→C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma
M-H Chen et al.
PHARMACOGENOMICS JOURNAL (2011)
The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer
K. D. Steffensen et al.
GYNECOLOGIC ONCOLOGY (2010)
Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer
Torben Frostrup Hansen et al.
VIRCHOWS ARCHIV (2010)
Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors
Susan A. J. Vaziri et al.
CURRENT ONCOLOGY REPORTS (2010)
Structure and Function of VEGF Receptors
Edward Stuttfeld et al.
IUBMB LIFE (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer
Jean-Louis Formento et al.
PHARMACOGENOMICS (2009)
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
Fan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
Anne M. Schultheis et al.
CLINICAL CANCER RESEARCH (2008)
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100
Bryan P. Schneider et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma
Brian I. Rini et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Vascular endothelial growth factor gene polymorphisms and serum levels in Behcet's disease
M. Kamoun et al.
TISSUE ANTIGENS (2008)
Pharmacogenetics of EGFR and VEGP inhibition
Jan Pander et al.
DRUG DISCOVERY TODAY (2007)
Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS
R. Zhai et al.
THORAX (2007)
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins
Samuel E. DePrimo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth
Pirjo Laakkonen et al.
CANCER RESEARCH (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease
Marc Ferrante et al.
INFLAMMATORY BOWEL DISEASES (2006)
Novel approaches in the therapy of metastatic renal cell carcinoma
JS Lam et al.
WORLD JOURNAL OF UROLOGY (2005)
Transcriptional regulation of the Vascular Endothelial Growth Factor gene -: a concert of activating factors
G Pagès et al.
CARDIOVASCULAR RESEARCH (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells
HY Jia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer
MI Koukourakis et al.
LUNG CANCER (2004)
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk
P Krippl et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes
T Awata et al.
DIABETES (2002)
A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels
W Renner et al.
JOURNAL OF VASCULAR RESEARCH (2000)
Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production
CJ Watson et al.
CYTOKINE (2000)
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
